ImClone (IMCL) said Monday that the mystery bidder that has flirted with paying $70 a share for the company will make up its mind by Wednesday.The company will either make a firm offer or withdraw by that deadline. ImClone said it will divulge the mystery suitor's name if it withdraws its proposal, according to an ImClone release. Last week, Bristol-Myers Squibb ( BMY) went hostile with its own bid for the company, raising it to $62 a share and going directly to shareholders. ImClone Chairman Carl Icahn dismissed the hostile tender offer as "misleading" and "absurd."
TheStreet.com BioTalk: IMCL, BMY